Immunological factors in the pathogenesis and treatment of age-related macular degeneration.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 15804763)

Published in Ocul Immunol Inflamm on February 01, 2005

Authors

A Kijlstra1, E La Heij, F Hendrikse

Author Affiliations

1: Eye Research Institute Maastricht, Department of Ophthalmology, University of Maastricht Maastricht The Netherlands. aize.kijlstra@wur.nl

Articles citing this

Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci (2006) 2.74

Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol (2007) 2.25

Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 1.55

Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation). Mediators Inflamm (2014) 1.20

Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol (2009) 1.09

Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model. J Neuroinflammation (2012) 1.04

Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells. Mol Vis (2010) 1.02

Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers. J Biol Chem (2011) 0.99

Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. J Ocul Pharmacol Ther (2012) 0.96

Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization. Invest Ophthalmol Vis Sci (2006) 0.95

IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells. Inflammation (2012) 0.94

Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner. J Biol Chem (2013) 0.92

Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology (2013) 0.92

Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement. Invest Ophthalmol Vis Sci (2012) 0.92

Biologically active fibronectin fragments stimulate release of MCP-1 and catabolic cytokines from murine retinal pigment epithelium. Invest Ophthalmol Vis Sci (2009) 0.88

Age-related macular degeneration and changes in the extracellular matrix. Med Sci Monit (2014) 0.88

Concise review: cell therapies: the route to widespread adoption. Stem Cells Transl Med (2012) 0.88

Combination of photodynamic therapy and immunomodulation: current status and future trends. Med Res Rev (2008) 0.85

Complement factor H gene polymorphisms and Chlamydia pneumoniae infection in age-related macular degeneration. Eye (Lond) (2009) 0.85

The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d. PLoS One (2013) 0.85

Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism. Mol Vis (2012) 0.81

Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells. Sci Rep (2016) 0.80

Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration. J Ophthalmol (2014) 0.77

Mycoplasma pneumoniae and Chlamydia pneumoniae seropositivity in patients with age-related macular degeneration. J Clin Med Res (2010) 0.77

FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Eye (Lond) (2014) 0.77

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone. Clin Ophthalmol (2008) 0.76

Serological association of Chlamydia pneumoniae infection with age-related macular degeneration: a systematic review and meta-analysis. PLoS One (2014) 0.75

Activated complement classical pathway in a murine model of oxygen-induced retinopathy. Int J Ophthalmol (2015) 0.75

Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes. J Ophthalmol (2015) 0.75

Anecortave acetate in the treatment of age-related macular degeneration. Clin Interv Aging (2006) 0.75

Articles by these authors

The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond) (2010) 1.32

Determinants of patient satisfaction after cataract surgery in 3 settings. J Cataract Refract Surg (2000) 1.21

Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci (1994) 1.08

Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol (2001) 1.05

Quality of care from the perspective of the cataract patient: the reliability and validity of the QUOTE-cataract. Br J Ophthalmol (2002) 0.98

Noninvasive assessment of the hydration gradient across the cornea using confocal Raman spectroscopy. Invest Ophthalmol Vis Sci (1998) 0.91

Results of scleral buckling operations in primary rhegmatogenous retinal detachment. Doc Ophthalmol (2000) 0.91

Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments. Retina (2001) 0.90

Cost effectiveness of foldable multifocal intraocular lenses compared to foldable monofocal intraocular lenses for cataract surgery. Br J Ophthalmol (2004) 0.86

Intraocular human thrombin infusion in diabetic vitrectomies. Ophthalmic Surg (1989) 0.86

Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3'5' guanosine monophosphate accumulation in retinal pigment epithelium cells. Br J Ophthalmol (2006) 0.86

Raman spectroscopy in ophthalmology: from experimental tool to applications in vivo. Lasers Med Sci (2001) 0.85

Asymmetrical vertical phorias indicating dissociated vertical deviation in subjects with normal binocular vision. Vision Res (1998) 0.85

A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks. Am J Ophthalmol (1988) 0.83

Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist. Eye (Lond) (2006) 0.82

Risk factors for redetachment and worse visual outcome after silicone oil removal in eyes with complicated retinal detachment. Eur J Ophthalmol (2007) 0.82

Decreased levels of cGMP in vitreous and subretinal fluid from eyes with retinal detachment. Br J Ophthalmol (2003) 0.82

Review and classification of corneal topographers. Lasers Med Sci (1999) 0.81

Retinal abnormalities in Alport's syndrome. Acta Ophthalmol (Copenh) (1988) 0.80

In vivo confocal Raman spectroscopy of the human cornea. Cornea (1999) 0.80

Levels of basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in subretinal fluid from patients with retinal detachment. Am J Ophthalmol (2001) 0.78

[Retinal detachments and retinal surgery]. Ned Tijdschr Geneeskd (1999) 0.78

Noninvasive Raman spectroscopic identification of intraocular lens material in the living human eye. J Cataract Refract Surg (2001) 0.78

Alagille syndrome in a family with duplication 20p11. Clin Dysmorphol (1996) 0.77

[Age-related macular degeneration; therapeutic options]. Ned Tijdschr Geneeskd (2001) 0.77

Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy. Int J Technol Assess Health Care (1999) 0.76

Non-invasive assessment of ocular pharmacokinetics using Confocal Raman Spectroscopy. J Ocul Pharmacol Ther (1999) 0.76

Yellow dye laser thermotherapy of choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol (2001) 0.75

Patient ignorance is the main reason for treatment delay in primary rhegmatogenous retinal detachment in The Netherlands. Eye (Lond) (2008) 0.75

[Medical education of tomorrow: a glance into the (near) future]. Ned Tijdschr Geneeskd (1998) 0.75

Iris angiography after cataract extraction and the effect of indomethacin eyedrops. Ophthalmologica (1984) 0.75

Noninvasive detection of ganciclovir in ocular tissue by Raman spectroscopy: implication for monitoring of drug release. J Ocul Pharmacol Ther (2002) 0.75

[Future need of eye care for patients with diabetes mellitus, costs and effectiveness]. Ned Tijdschr Geneeskd (1995) 0.75

Development of a wide field height eye topographer: validation on models of the anterior eye surface. Optom Vis Sci (1998) 0.75

[Treatment of glaucoma using argon lasers]. Bull Mem Soc Fr Ophtalmol (1983) 0.75

[The treatment of diabetic retinopathy: past, present and future]. Ned Tijdschr Geneeskd (1989) 0.75

[Laser treatment in ophthalmology]. Ned Tijdschr Geneeskd (1984) 0.75

Risk factors for redetachment and worse visual outcome after silicone oil removal in eyes with complicated retinal detachment. Eur J Ophthalmol (2017) 0.75

[Dendritic keratitis in a family practice]. Ned Tijdschr Geneeskd (1986) 0.75

[Terson's syndrome]. Ned Tijdschr Geneeskd (1984) 0.75

[Intra-photocoagulation during vitrectomy]. Ophtalmologie (1989) 0.75

Non-invasive monitoring of commonly used intraocular drugs against endophthalmitis by Raman spectroscopy. Lasers Surg Med (2003) 0.75

[Chronic serous central retinopathy]. Bull Mem Soc Fr Ophtalmol (1986) 0.75

[Surgical treatment of severe proliferative diabetic retinopathy]. Ned Tijdschr Geneeskd (1989) 0.75

[An epidemic of keratoconjunctivitis]. Ned Tijdschr Geneeskd (1984) 0.75

Identification of intraocular lens materials using confocal Raman spectroscopy. J Cataract Refract Surg (1999) 0.75